Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Artemisinin-based combination therapy for ... - The Cochrane Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Analysis 9.10. Comparison 9 Artemether-lumefantrine vs Artesunate plus amodiaquine, Outcome 10<br />
Sensitivity analysis: Total Failure Day 28 PCR adjusted.<br />
Review: <strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria<br />
Comparison: 9 Artemether-lumefantrine vs Artesunate plus amodiaquine<br />
Outcome: 10 Sensitivity analysis: Total Failure Day 28 PCR adjusted<br />
Study or subgroup AL6 AS+AQ Risk Ratio Risk Ratio<br />
1 Total Failure (P. falciparum) Day 28 PCR adjusted<br />
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI<br />
Faye 2003 SEN 0/147 0/340 0.0 [ 0.0, 0.0 ]<br />
Guthmann 2004 AGO 0/59 0/60 0.0 [ 0.0, 0.0 ]<br />
Falade 2005 NGA 0/59 0/56 0.0 [ 0.0, 0.0 ]<br />
Bukirwa 2005 UGA 2/102 0/68 3.35 [ 0.16, 68.71 ]<br />
Owusu-Agyei 2006 GHA 12/122 7/136 1.91 [ 0.78, 4.70 ]<br />
Dorsey 2006 UGA 0/95 2/100 0.21 [ 0.01, 4.33 ]<br />
Adjei 2006 GHA 4/101 2/104 2.06 [ 0.39, 11.00 ]<br />
Kobbe 2007 GHA 12/92 7/88 1.64 [ 0.68, 3.97 ]<br />
Subtotal (95% CI) 777 952 1.65 [ 0.95, 2.87 ]<br />
Total events: 30 (AL6), 18 (AS+AQ)<br />
Heterogeneity: Chi 2 = 2.16, df = 4 (P = 0.71); I 2 =0.0%<br />
Test <strong>for</strong> overall effect: Z = 1.77 (P = 0.077)<br />
2 Total Failure Day 28 PCR adjusted (trials with baseline differences included)<br />
Faye 2003 SEN 0/147 0/340 0.0 [ 0.0, 0.0 ]<br />
Martensson 2003 TZA 5/188 13/162 0.33 [ 0.12, 0.91 ]<br />
Koram 2003 GHA 1/40 0/38 2.85 [ 0.12, 67.97 ]<br />
Guthmann 2004 AGO 0/59 0/60 0.0 [ 0.0, 0.0 ]<br />
Van den Broek 2004 ZAR 0/87 1/67 0.26 [ 0.01, 6.22 ]<br />
Bukirwa 2005 UGA 2/102 0/68 3.35 [ 0.16, 68.71 ]<br />
Falade 2005 NGA 0/59 0/56 0.0 [ 0.0, 0.0 ]<br />
Adjei 2006 GHA 4/101 2/104 2.06 [ 0.39, 11.00 ]<br />
Dorsey 2006 UGA 0/95 2/100 0.21 [ 0.01, 4.33 ]<br />
Owusu-Agyei 2006 GHA 12/122 7/136 1.91 [ 0.78, 4.70 ]<br />
Kobbe 2007 GHA 12/92 7/88 1.64 [ 0.68, 3.97 ]<br />
Subtotal (95% CI) 1092 1219 1.07 [ 0.69, 1.67 ]<br />
Total events: 36 (AL6), 32 (AS+AQ)<br />
<strong>Artemisinin</strong>-<strong>based</strong> <strong>combination</strong> <strong>therapy</strong> <strong>for</strong> treating uncomplicated malaria (Review)<br />
Copyright © 2009 <strong>The</strong> <strong>Cochrane</strong> Collaboration. Published by John Wiley & Sons, Ltd.<br />
0.001 0.01 0.1 1 10 100 1000<br />
Favours AL6 Favours AS+AQ<br />
(Continued ...)<br />
174